Reference number : 172-2018-2019-Q3-916320, amendment number : , agreement type : C, recipient legal name : KMT Hepatech Inc., recipient country : CA, recipient province : AB, recipient city : Edmonton|Edmonton, recipient postal code : T6G 2M9, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Establishing the production of fresh hepatocytes isolated from chimeric mouse with humanized liver, agreement title french : Établir la production d'hépatocytes frais isolés de souris chimériques avec foie humanisé, agreement number : 916320, agreement value : 116000.0, agreement start date : 2018-11-01, agreement end date : 2019-10-31, description english : The project goal is to establish the sustainable production of PXB-Cells® (hepatocytes isolated from chimeric mouse with humanized liver) at KMT Hepatech facility in Edmonton. Quality Control procedures and packing process for shipment will be optimized., description french : Établir la production d'hépatocytes frais isolés de souris chimériques avec foie humanisé, expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada